(Q31773)

Statements

Trans depathologisation and gender identity disorder in Japan: A critical discourse analysis of medical literature, 2010-2022. (English)
1 reference
Since the depathologisation movement in 2007 to challenge the pathologisation of trans identities in Western psychiatry, significant developments have occurred, including revisions to Standards of Care and diagnostic criteria such as ICD-11's gender incongruence and DSM-5's gender dysphoria, acknowledging gender diversity as an expected part of human development. (English)
Copyright © 2024 The Author. Published by Elsevier Ltd.. All rights reserved. (English)
1 reference
This paper argues that Japanese medical models reflect global issues but also have unique aspects shaped by cultural and linguistic nuances. (English)
Copyright © 2024 The Author. Published by Elsevier Ltd.. All rights reserved. (English)
1 reference
Using critical discourse analysis, this paper examines how depathologisation discourses are perceived in the Japanese medical community, focusing on the term seidouitsusei-syōgai (gender identity disorder), presenting three ways in which seidouitsusei-syōgai is used: psychiatric disorder, syōgai/sikkan (impairment/disability/disorder), and diagnostic category. (English)
Copyright © 2024 The Author. Published by Elsevier Ltd.. All rights reserved. (English)
1 reference
These uses are influenced by legal and social reforms, healthcare access and alignment with international classifications, while the medical profession's authority remains unexamined. (English)
Copyright © 2024 The Author. Published by Elsevier Ltd.. All rights reserved. (English)
1 reference
Reflecting the structural challenges of diagnostic models in trans medicine, the interpretation of seidouitsusei-syōgai differs from the English phrase 'gender identity disorder' due to the specific connotations of syōgai in the Japanese context. (English)
Copyright © 2024 The Author. Published by Elsevier Ltd.. All rights reserved. (English)
1 reference
By examining Japan's approach to depathologisation and medicalisation, this paper enriches the understanding of trans medicine and the impact of depathologisation discourse in Japan. (English)
Copyright © 2024 The Author. Published by Elsevier Ltd.. All rights reserved. (English)
1 reference
July 2024
1 reference
July 2024
1 reference
353
1 reference
117039
1 reference
117039
1 reference
S0277-9536(24)00492-1
1 reference
Declaration of competing interest None. (English)
1 reference